KAUST signed an MoU with MISA and Novo Nordisk at the Riyadh Global Medical Biotechnology Summit 2023. The agreement aims to address healthcare challenges in Saudi Arabia and develop the biotech and pharma sector through knowledge transfer and research. A key objective is to establish a Novo Nordisk Center of Excellence focused on obesity and metabolic research. Why it matters: The partnership will boost Saudi Arabia's Vision 2030 goals of creating tech-driven industries and improving health outcomes through biotechnology.
The Saudi Ministry of Health and KAUST have signed an agreement to boost collaboration in healthcare innovation and investment. The partnership aims to develop a sustainable ecosystem supporting applied research and advanced technologies in healthcare, aligning with Saudi Vision 2030. The collaboration includes joint initiatives, workshops, training, and data exchange to enhance health innovation. Why it matters: This agreement signifies a strong push towards AI-based healthcare and precision medicine in Saudi Arabia, leveraging academic research for practical applications.
KAUST and Janssen Pharmaceutical (Johnson & Johnson) are collaborating to research and innovate in neglected tropical diseases, focusing on dengue fever. They signed an MoU to establish a dengue fever research program and an infectious disease R&D center at KAUST's National BioPark. The partnership marks Johnson & Johnson's first university collaboration in Saudi Arabia. Why it matters: This collaboration signifies a major step in localizing disease research within Saudi Arabia and leveraging KAUST's AI, genomics, and data simulation expertise to address global health challenges.
KAUST is collaborating with medical centers and Alfaisal University to integrate smart and digital tools into the Saudi healthcare system. A key objective is to improve understanding of disease mechanisms for better diagnosis, treatment, and prevention, aligning with KSA's Vision 2030. KAUST has partnered with Alfaisal University to establish the Kingdom’s first M.D./Ph.D. program. Why it matters: These partnerships aim to transition Saudi Arabia's healthcare system towards precision and personalized medicine by training practitioners in AI and smart technologies.
The KAUST Smart-Health Initiative (KSHI) held its annual forum, showcasing research collaborations with partners like KFSHRC, KAIMRC, and KACST. Projects presented included biomarker detection devices, cardiovascular disease sensors, 3D data visualization, and genome sequencing for patient data analysis. Dr. Sara F. Althari highlighted KAUST's cultivation of partnerships within the Kingdom's healthcare and biotech ecosystem. Why it matters: The KSHI aims to transform Saudi Arabia's healthcare system towards precision and personalized medicine, aligning with Vision 2030.